Diagnosing Prostate Cancer: Moving Beyond PSAs, Gleason Scores and Biopsies Through Advanced Imaging

Andrei Iagaru, MD, a radiologist and nuclear medicine specialist at Stanford Health Care, describes how breakthrough molecular imaging technologies measure cancer’s very biology to illuminate options for prostate cancer treatment. Learn more about how PET/CTs and PET/MRIs detect certain molecules expressed by prostate cancer and what that means for treatment options today and in the future.